Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$47.7K
6.51K shares
What this filing means
SWARTZ ROBIN plans to sell 6.51K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $47.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/21/2024ACC: 0001959173-24-001232
Officer· Chief Operating Officer
Since Feb 2022
6.51K
Shares to sell
$47.7K
Approx. market value
3.97K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/16/2024
3.97KTotal acquired3.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/16/2024 | Restricted Stock Vesting Compensation | 3.97K | — |
| Total | 3.97K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.54K
Market value
$18.2K
1/17/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.97K
Market value
$29.6K
2/21/2024
Total
Units
6.51K
Value
$47.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/17/2024 | 2.54K | $18.2K | — | Completed |
| Planned — Approximate Date | ||||
2/21/2024 | 3.97K | $29.6K | NASDAQ | Planned |
| Total | 6.51K | $47.7K | ||